LOJACONO, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 8.893
EU - Europa 4.384
AS - Asia 3.755
SA - Sud America 692
Continente sconosciuto - Info sul continente non disponibili 233
AF - Africa 94
OC - Oceania 16
Totale 18.067
Nazione #
US - Stati Uniti d'America 8.721
CN - Cina 1.368
SG - Singapore 1.267
UA - Ucraina 815
DE - Germania 766
PL - Polonia 683
IT - Italia 657
BR - Brasile 569
HK - Hong Kong 417
FR - Francia 336
GB - Regno Unito 267
FI - Finlandia 249
RU - Federazione Russa 220
VN - Vietnam 182
TR - Turchia 137
IE - Irlanda 130
IN - India 109
EE - Estonia 97
BD - Bangladesh 88
CA - Canada 65
MX - Messico 55
SE - Svezia 37
ZA - Sudafrica 36
AR - Argentina 32
EC - Ecuador 25
IQ - Iraq 25
BE - Belgio 21
NL - Olanda 21
ID - Indonesia 20
JP - Giappone 20
NG - Nigeria 19
SA - Arabia Saudita 19
CO - Colombia 18
ES - Italia 17
AU - Australia 15
PK - Pakistan 15
UZ - Uzbekistan 14
AT - Austria 13
JM - Giamaica 13
CL - Cile 12
VE - Venezuela 12
EG - Egitto 9
EU - Europa 8
TT - Trinidad e Tobago 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 7
DZ - Algeria 7
HN - Honduras 7
NI - Nicaragua 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
IR - Iran 6
KZ - Kazakistan 6
PH - Filippine 6
JO - Giordania 5
MU - Mauritius 5
NP - Nepal 5
PE - Perù 5
PY - Paraguay 5
RS - Serbia 5
BG - Bulgaria 4
BH - Bahrain 4
BO - Bolivia 4
HR - Croazia 4
LT - Lituania 4
MA - Marocco 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
GR - Grecia 3
GT - Guatemala 3
HU - Ungheria 3
KG - Kirghizistan 3
LV - Lettonia 3
MY - Malesia 3
OM - Oman 3
PT - Portogallo 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
ET - Etiopia 2
GD - Grenada 2
KE - Kenya 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
Totale 17.828
Città #
Fairfield 815
Ashburn 784
Woodbridge 711
Singapore 696
Warsaw 679
Jacksonville 576
San Jose 446
Houston 444
Hong Kong 411
Ann Arbor 344
Chandler 323
Cambridge 319
Seattle 303
Beijing 286
Wilmington 284
The Dalles 247
Princeton 245
Council Bluffs 233
Nanjing 220
New York 212
Los Angeles 210
Buffalo 135
Helsinki 132
Dublin 130
Istanbul 113
Lauterbourg 107
Columbus 101
Tallinn 93
Nanchang 83
São Paulo 73
Des Moines 69
Dearborn 66
Milan 64
Ho Chi Minh City 61
Moscow 60
Shenyang 56
Munich 54
Santa Clara 54
Lancaster 53
Hebei 47
San Diego 47
Rome 46
Changsha 45
Dallas 45
Shanghai 42
Verona 39
Brescia 38
San Francisco 37
Hanoi 35
Jinan 35
Tianjin 35
Chicago 33
Jiaxing 29
Chennai 27
Nürnberg 26
Phoenix 26
Hangzhou 25
Redondo Beach 23
London 22
Zhengzhou 22
Denver 21
Guangzhou 21
Brussels 20
Genova 20
Abuja 19
Naples 19
Orem 19
Tokyo 19
Dong Ket 18
Johannesburg 18
Taizhou 17
Toronto 17
Boardman 16
Rio de Janeiro 16
Brooklyn 15
Belo Horizonte 14
Brasília 14
Charlotte 14
Ningbo 14
Mexico City 13
Mumbai 13
Poplar 13
Tashkent 13
Turku 13
Dhaka 12
Monterrey 12
Nuremberg 12
Amsterdam 11
Baghdad 11
Bologna 11
Guayaquil 11
Kunming 11
Lanzhou 11
Manchester 11
Atlanta 10
Falkenstein 10
Montreal 10
Porto Alegre 10
Riyadh 10
Turin 10
Totale 11.585
Nome #
Bambini pretermine: nati per vivere 375
Variabili psicologiche materne e andamento del parto: rilevazione in un campione di donne italiane alla prima esperienza di parto. 347
Parto e puerperio: i vissuti delle donne in un'ottica di ricerca multidisciplinare. 341
EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome 339
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 336
Percorso nascita: un progetto di ricerca multidisciplinare. 302
Long-term outcome of children of rheumatic disease patients 242
The role of second trimester uterine artery Doppler in pregnancies with systemic lupus erythematosus 222
L’approccio multidisciplinare alla nascita: parto, puerperio, visti dalle donne. 213
L’approccio multidisciplinare alla nascita: parto e puerperio visti dalle donne. 211
Cerebroplacental ratio before induction of labour in normally grown fetuses at term and intrapartum fetal compromise 202
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry) 200
A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus 198
Dinoprostone per l'induzione del travaglio di parto in pazienti con Bishop score favorevole: confronto tra gel vaginale e pessario vaginale a rilascio prolungato 189
Children born to SLE and APS mothers 186
Subpopulations of anti-β₂glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of β₂glycoprotein I 182
Pregnancy in autoimmune rheumatic diseases: the importance of counselling for old and new challenges. 182
A randomized controlled trial of 24-hour vaginal dinoprostone pessary compared to gel for induction of labor in term pregnancies with a Bishop score 176
Systemic vasculitis and pregnancy: a multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 175
Thrombophilia is significantly associated with severe preeclampsia: results of a large-scale, case-controlled study 174
Uterine artery velocimetry in patients with gestational hypertension 173
Brief Report: Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 173
Pregnancy implications for systemic lupus erythematosus and the antiphospholipid syndrome 168
The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes 168
Prophylactic oral nifedipine to reduce preterm delivery: a randomized controlled trial in women at high risk 166
Labor course and delivery in epidural analgesia: a case-control study 163
Correlation of fetal DNA levels in maternal plasma with Doppler status in pathological pregnancies 162
Quantitative analysis of fetal DNA in maternal plasma in pathological conditions associated with placental abnormalities. 161
Pregnancy complications of the antiphospholipid syndrome 160
Long-term neurodevelopmental outcome of children born to prospectively followed pregnancies of women with systemic lupus erythematosus and/or antiphospholipid syndrome 159
Risk factors for adverse maternal and fetal outcomes in women with confirmed aPL positivity: Results from a multicenter study of 283 pregnancies 159
Insulinoma Identified in Puerperium: Association with Pregnancy and Literature Review 157
Cerebral ultrasound abnormalities in infants born to mothers with autoimmune disease 155
Neuropsychological development of children born to patients with systemic lupus erythematosus 154
Impact of in utero environment on the offspring of lupus patients 154
Autoimmunity and pregnancy: autoantibodies and pregnancy in rheumatic diseases 153
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women 152
Offspring of Women with Systemic Autoimmune diseases: fetal and neonatal complications and inheritance of autoimmune diseases. 152
PROSPECTIVELY FOLLOWED PREGNANCIES IN PATIENTS WITH SYSTEMIC VASCULITIS: STILL MANY PROBLEMS ON BOTH FOETAL AND MATERNAL SIDE 151
Follow up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation 149
Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. 149
Neonatal outcome in patients with rheumatic disease 148
Predictors of maternal and fetal complications in SLE patients: a prospective study 148
Idiopathic eosinophilic pneumonia and pregnancy: report of a case. 147
Anticardiolipin and anti-beta2 glycoprotein I antibodies in infants born to mothers with antiphospholipid antibody-positive autoimmune disease: a follow-up study 146
Immune system development in infants born to mothers with autoimmune disease, exposed in utero to immunosuppressive agents 142
Infertility in women with systemic autoimmune diseases 142
European registry of babies born to mothers with antiphospholipid syndrome. 141
Neuropsychological development of children born to patients with antiphospholipid syndrome. 140
THE FINE SPECIFICITY OF ANTI-BETA2GLYCOPROTEIN I ANTIBODIES IN SYSTEMIC AUTOIMMUNE DISEASES IS PREFERENTIALLY DIRECTED AGAINST DOMAIN 1 139
Systemic and fetal-maternal nitric oxide synthesis in normal pregnancy and in preeclampsia 138
Neonatal effects of maternal antiphospholipid syndrome. 138
Lupus and the antiphospholipid syndrome in pregnancy and obstetrics: clinical characteristics, diagnosis, pathogenesis, and treatment. 137
Variabili psicologiche materne e andamento clinico del parto 137
The Efficacy and Safety of Cyclosporin A in Pregnant Patients with Systemic Autoimmune Diseases 137
Pregnancy and neonatal outcome in primary antiphospholipid syndrome. 136
Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome 136
Anti-{beta}2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their 'innocent' profile? 136
Atypical presentation and imaging features of postpartum posterior reversible encephalopathy syndrome 136
Neonates born from mothers with autoimmune disorders 135
The combination of short cervical length and phIGFBP-1 in the prediction of preterm delivery in symptomatic women. 135
Assistenza e sorveglianza nel travaglio di parto a basso rischio 134
Autoantibodies and prediction of reproductive failure. 134
Disease course and obstetric outcomes of pregnancies in juvenile idiopathic arthritis: are there any differences among disease subtypes? A single-centre retrospective study of prospectively followed pregnancies in a dedicated pregnancy clinic 133
Maternal cardiovascular function in pregnancies complicated by intrauterine growth restriction 131
Transabdominal uterine arteries Doppler between 11-14 weeks of gestation for prediction of outcome in high risk pregnancies 131
Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis 130
Complement Activation and Pregnancy Failure. 129
Anti beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome 128
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases 127
Finespecificity of anti-B2glycoprotein I antibodies in sysemic autoimmune diseasesis mostly directed against domain 1 124
Labor induction with misoprostol vaginal insert compared with dinoprostone vaginal insert 124
Is it possible to differentiate "Natural" Antiphospholipid antibodies from "Thrombophilic" ones? Analysis of the fine specificity against the domains of Beta2glycoprotein I 123
Correlation between fetal Doppler indices and neonatal acid–base status at birth in healthy appropriate for gestational age term fetuses 122
Beta 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome 121
Antiphospholipid and anti beta 2 glycoprotein I antibodies in patients with obstetrical complications 121
Autoimmune diseases and pregnancy 121
Reproductive Issues and Pregnancy Implications in Systemic Sclerosis. 121
Gestational success in patients at risk of preterm labor with presence of ureaplasma urealyticum in cervico-vaginal secretions 119
IgG anti-B2glycoprotein I antibodies form one-year-old children born to mothers with systemic autoimmune diseases preferentially target domain 4/5 119
Pregnancy in systemic sclerosis: a prospective study 119
Systemic lupus erythematosus and pregnancy: a prospective study. 118
Esperienza personale nel trattamento delle emorragie gastroduodenali mediante l'associazione di somatostatina e ranitidina 118
External cephalic version for breech presentation at term: an effective procedure to reduce the caesarean section rate 117
Outcome of infants from mothers with anti-SSA/Ro antibodies. 117
LA FINE SPECIFICITA' DEGLI ANTICORPI ANTI-BETA2GLICOPROTEINA I NELLE MALATTIE AUTOIMMUNI SISTEMICHE E' PREVALENTEMENTE DIRETTA ERSO IL DOMINIO 1 116
Novel aspects of Sjögren’s syndrome in 2012 116
Contraception in adolescents with systemic lupus erythematosus 115
ANTICORPI ANTIFOSFOLIPIDI: E' POSSIBILE DISTINGUERE GLI ANTICORPI "INNOCENTI" DA QUELLI "TROMBOFILICI"? ANALISI DELLA FINE SPECIFICITA' DIRETTA VERSO I DOMINI DELLA BETA2GLICOPROTEINA I 114
LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME 114
Thrombophilia is a risk factor for severe preeclampsia and its recurrence 111
Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: A multicenter study on 62 pregnancies 111
Obstetric manifestation of the Antiphospholipid Syndrome 110
Utilità dell’ambulatorio del parto pretermine nelle pazienti ad alto rischio anamnestico e/o attuale. 109
Cytokine gene polymorphisms and preeclampsia 109
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre study. 109
ONE-YEAR-OLD CHILDREN BORN TO MOTHERS WITH SYSTEMIC AUTOIMMUNE DISEASES MAY DEVELOP ANTI-BETA2GPI IGG ANTIBODIES THAT PREFERENTIALLY TARGET DOMAIN 4/5 108
SICUREZZA DEI FARMACI BIOLOGICI ANTI-TNF IN GRAVIDANZA 108
Streptococcus group B and pregnancy: the therapeutic role of topical intravaginal clindamycin 107
Role of Doppler velocimetry of uterine arteries and ambulatory blood pressure monitoring in detecting pregnancies at risk for preeclampsia 106
Totale 15.568
Categoria #
all - tutte 80.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022723 0 0 0 49 13 50 38 67 41 119 93 253
2022/20231.017 138 7 26 78 104 261 4 105 173 5 42 74
2023/2024859 75 27 50 71 36 158 33 37 217 15 2 138
2024/20252.102 9 26 14 342 213 198 177 85 199 134 431 274
2025/20264.088 377 596 397 577 357 262 615 125 228 342 140 72
2026/20271.250 219 199 377 455 0 0 0 0 0 0 0 0
Totale 18.067